Search
| Leader | 00000nz a2200037n 45 0 | ||
|---|---|---|---|
| 001 | WKP|Q59140272 (VIAF cluster) (Authority/Source Record) | ||
| 003 | WKP | ||
| 005 | 20241121000209.0 | ||
| 008 | 241121nneanz||abbn n and d | ||
| 035 | ‡a (WKP)Q59140272 | ||
| 024 | ‡a 0000-0003-0160-5565 ‡2 orcid | ||
| 035 | ‡a (OCoLC)Q59140272 | ||
| 100 | 0 | ‡a Eduardo Pérez-Gómez ‡c researcher ORCID ID = 0000-0003-0160-5565 ‡9 en | |
| 375 | ‡a 1 ‡2 iso5218 | ||
| 400 | 0 | ‡a Eduardo Pérez-Gómez ‡c onderzoeker ‡9 nl | |
| 670 | ‡a Author's A Dual Role for FADD in Human Precursor T-Cell Neoplasms | ||
| 670 | ‡a Author's A role for endoglin as a suppressor of malignancy during mouse skin carcinogenesis | ||
| 670 | ‡a Author's A role for the Fas/FasL system in modulating genetic susceptibility to T-cell lymphoblastic lymphomas | ||
| 670 | ‡a Author's Cannabinoids: a new hope for breast cancer therapy? | ||
| 670 | ‡a Author's Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition. | ||
| 670 | ‡a Author's Characterization of murine S-endoglin isoform and its effects on tumor development. | ||
| 670 | ‡a Author's Efficient in vivo antitumor effect of an immunotoxin based on ribotoxin α-sarcin in nude mice bearing human colorectal cancer xenografts. | ||
| 670 | ‡a Author's Expression of the TGF-beta coreceptor endoglin in epidermal keratinocytes and its dual role in multistage mouse skin carcinogenesis. | ||
| 670 | ‡a Author's Impaired wound repair in adult endoglin heterozygous mice associated with lower NO bioavailability. | ||
| 670 | ‡a Author's Loss of Tribbles pseudokinase-3 promotes Akt-driven tumorigenesis via FOXO inactivation. | ||
| 670 | ‡a Author's Lysyl oxidase-like 2 as a new poor prognosis marker of squamous cell carcinomas | ||
| 670 | ‡a Author's Podoplanin associates with CD44 to promote directional cell migration | ||
| 670 | ‡a Author's Role of cannabinoid receptor CB2 in HER2 pro-oncogenic signaling in breast cancer | ||
| 670 | ‡a Author's S194-P-FADD as a marker of aggressiveness and poor prognosis in human T-cell lymphoblastic lymphoma | ||
| 670 | ‡a Author's Soluble endoglin antagonizes Met signaling in spindle carcinoma cells. | ||
| 670 | ‡a Author's Targeting CB2-GPR55 receptor heteromers modulates cancer cell signaling. | ||
| 670 | ‡a Author's The orphan G protein-coupled receptor GPR55 promotes cancer cell proliferation via ERK | ||
| 670 | ‡a Author's The orphan receptor GPR55 drives skin carcinogenesis and is upregulated in human squamous cell carcinomas. | ||
| 670 | ‡a Author's The role of the TGF-β coreceptor endoglin in cancer | ||
| 670 | ‡a Author's The TGF-beta co-receptor endoglin modulates the expression and transforming potential of H-Ras | ||
| 909 | ‡a (orcid) 0000000301605565 ‡9 1 | ||
| 919 | ‡a dualroleforfaddinhumanprecursortcellneoplasms ‡A A Dual Role for FADD in Human Precursor T-Cell Neoplasms ‡9 1 | ||
| 919 | ‡a roleforendoglinasasuppressorofmalignancyduringmouseskincarcinogenesis ‡A A role for endoglin as a suppressor of malignancy during mouse skin carcinogenesis ‡9 1 | ||
| 919 | ‡a roleforthefasfaslsysteminmodulatinggeneticsusceptibilitytotcelllymphoblasticlymphomas ‡A A role for the Fas/FasL system in modulating genetic susceptibility to T-cell lymphoblastic lymphomas ‡9 1 | ||
| 919 | ‡a cannabinoidsanewhopeforbreastcancertherapy ‡A Cannabinoids: a new hope for breast cancer therapy? ‡9 1 | ||
| 919 | ‡a cannabinoidsreduceerbb2drivenbreastcancerprogressionthroughaktinhibition ‡A Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition. ‡9 1 | ||
| 919 | ‡a characterizationofmurinesendoglinisoformanditseffectsontumordevelopment ‡A Characterization of murine S-endoglin isoform and its effects on tumor development. ‡9 1 | ||
| 919 | ‡a efficientinvivoantitumoreffectofanimmunotoxinbasedonribotoxinαsarcininnudemicebearinghumancolorectalcancerxenografts ‡A Efficient in vivo antitumor effect of an immunotoxin based on ribotoxin α-sarcin in nude mice bearing human colorectal cancer xenografts. ‡9 1 | ||
| 919 | ‡a expressionofthetgfbetacoreceptorendoglininepidermalkeratinocytesanditsdualroleinmultistagemouseskincarcinogenesis ‡A Expression of the TGF-beta coreceptor endoglin in epidermal keratinocytes and its dual role in multistage mouse skin carcinogenesis. ‡9 1 | ||
| 919 | ‡a impairedwoundrepairinadultendoglinheterozygousmiceassociatedwithlowernobioavailability ‡A Impaired wound repair in adult endoglin heterozygous mice associated with lower NO bioavailability. ‡9 1 | ||
| 919 | ‡a lossoftribblespseudokinase3promotesaktdriventumorigenesisviafoxoinactivation ‡A Loss of Tribbles pseudokinase-3 promotes Akt-driven tumorigenesis via FOXO inactivation. ‡9 1 | ||
| 919 | ‡a lysyloxidaselike2asanewpoorprognosismarkerofsquamouscellcarcinomas ‡A Lysyl oxidase-like 2 as a new poor prognosis marker of squamous cell carcinomas ‡9 1 | ||
| 919 | ‡a podoplaninassociateswithcd44topromotedirectionalcellmigration ‡A Podoplanin associates with CD44 to promote directional cell migration ‡9 1 | ||
| 919 | ‡a roleofcannabinoidreceptorcb2inher2prooncogenicsignalinginbreastcancer ‡A Role of cannabinoid receptor CB2 in HER2 pro-oncogenic signaling in breast cancer ‡9 1 | ||
| 919 | ‡a s194pfaddasamarkerofaggressivenessandpoorprognosisinhumantcelllymphoblasticlymphoma ‡A S194-P-FADD as a marker of aggressiveness and poor prognosis in human T-cell lymphoblastic lymphoma ‡9 1 | ||
| 919 | ‡a solubleendoglinantagonizesmetsignalinginspindlecarcinomacells ‡A Soluble endoglin antagonizes Met signaling in spindle carcinoma cells. ‡9 1 | ||
| 919 | ‡a targetingcb2gpr55receptorheteromersmodulatescancercellsignaling ‡A Targeting CB2-GPR55 receptor heteromers modulates cancer cell signaling. ‡9 1 | ||
| 919 | ‡a orphangproteincoupledreceptorgpr55promotescancercellproliferationviaerk ‡A The orphan G protein-coupled receptor GPR55 promotes cancer cell proliferation via ERK ‡9 1 | ||
| 919 | ‡a orphanreceptorgpr55drivesskincarcinogenesisandisupregulatedinhumansquamouscellcarcinomas ‡A The orphan receptor GPR55 drives skin carcinogenesis and is upregulated in human squamous cell carcinomas. ‡9 1 | ||
| 919 | ‡a roleofthetgfβcoreceptorendoglinincancer ‡A The role of the TGF-β coreceptor endoglin in cancer ‡9 1 | ||
| 919 | ‡a tgfbetacoreceptorendoglinmodulatestheexpressionandtransformingpotentialofhras ‡A The TGF-beta co-receptor endoglin modulates the expression and transforming potential of H-Ras ‡9 1 | ||
| 946 | ‡a b ‡9 1 | ||
| 996 | ‡2 LC|no2009184392 | ||
| 996 | ‡2 J9U|987007327655705171 | ||
| 996 | ‡2 NII|DA14770185 | ||
| 996 | ‡2 ISNI|0000000377530483 | ||
| 996 | ‡2 J9U|987007330143605171 | ||
| 996 | ‡2 BLBNB|000679542 | ||
| 996 | ‡2 BIBSYS|14018675 | ||
| 996 | ‡2 LC|n 93071816 | ||
| 996 | ‡2 DBC|87097990825917 | ||
| 996 | ‡2 NTA|33062525X | ||
| 996 | ‡2 BNC|981058611544306706 | ||
| 996 | ‡2 LC|ns2022002238 | ||
| 996 | ‡2 BNE|XX1260518 | ||
| 996 | ‡2 ISNI|0000000504442567 | ||
| 996 | ‡2 LC|no2020066632 | ||
| 996 | ‡2 LC|no 00078094 | ||
| 996 | ‡2 DNB|1157243509 | ||
| 996 | ‡2 CAOONL|ncf13734071 | ||
| 996 | ‡2 BNF|13619126 | ||
| 996 | ‡2 NUKAT|n 2010141302 | ||
| 996 | ‡2 DNB|1159729670 | ||
| 996 | ‡2 LC|n 85822240 | ||
| 996 | ‡2 SUDOC|032849826 | ||
| 996 | ‡2 BNCHL|10000000000000000081931 | ||
| 996 | ‡2 DNB|1333366175 | ||
| 996 | ‡2 NTA|073622419 | ||
| 996 | ‡2 BNE|XX5608816 | ||
| 996 | ‡2 SUDOC|228065194 | ||
| 996 | ‡2 DNB|1056542497 | ||
| 996 | ‡2 NTA|071042792 | ||
| 996 | ‡2 ISNI|0000000120653488 | ||
| 996 | ‡2 ISNI|0000000060974078 | ||
| 996 | ‡2 ISNI|0000000114766953 | ||
| 996 | ‡2 NKC|xx0061298 | ||
| 996 | ‡2 BNE|XX950758 | ||
| 996 | ‡2 ISNI|0000000080181008 | ||
| 996 | ‡2 RERO|A003307022 | ||
| 996 | ‡2 BNCHL|10000000000000000266999 | ||
| 996 | ‡2 BNCHL|10000000000000000007312 | ||
| 996 | ‡2 NKC|xx0062910 | ||
| 996 | ‡2 BNCHL|10000000000000000065217 | ||
| 996 | ‡2 BNE|XX5853808 | ||
| 996 | ‡2 J9U|987011084188405171 | ||
| 996 | ‡2 BNE|XX6087717 | ||
| 996 | ‡2 DNB|140892699 | ||
| 996 | ‡2 ISNI|0000000059568697 | ||
| 996 | ‡2 RERO|A006270926 | ||
| 996 | ‡2 NUKAT|n 2015136544 | ||
| 996 | ‡2 NDL|00925587 | ||
| 996 | ‡2 NKC|vse2007365328 | ||
| 996 | ‡2 ISNI|0000000108356042 | ||
| 996 | ‡2 BNE|XX4579532 | ||
| 996 | ‡2 BNC|981058523207106706 | ||
| 996 | ‡2 ISNI|0000000059943207 | ||
| 996 | ‡2 BNE|XX1247321 | ||
| 996 | ‡2 BNF|16358913 | ||
| 996 | ‡2 LC|n 2020184782 | ||
| 996 | ‡2 BNE|XX5447499 | ||
| 996 | ‡2 PLWABN|9810650085005606 | ||
| 996 | ‡2 LIH|LNB:_g_1P;=BO | ||
| 996 | ‡2 ISNI|0000000122832543 | ||
| 996 | ‡2 J9U|987007605502305171 | ||
| 996 | ‡2 BNE|XX1437189 | ||
| 996 | ‡2 DNB|13171905X | ||
| 996 | ‡2 NSK|000568970 | ||
| 996 | ‡2 CAOONL|ncf11323716 | ||
| 996 | ‡2 ISNI|0000000081057797 | ||
| 996 | ‡2 LC|nb2011015961 | ||
| 996 | ‡2 LC|n 88014920 | ||
| 996 | ‡2 BNC|981058526304406706 | ||
| 996 | ‡2 LC|no2021014454 | ||
| 996 | ‡2 ISNI|0000000059566114 | ||
| 996 | ‡2 BNE|XX854988 | ||
| 996 | ‡2 ISNI|0000000512275957 | ||
| 996 | ‡2 DNB|1056329912 | ||
| 996 | ‡2 ISNI|0000000047368583 | ||
| 996 | ‡2 NYNYRILM|111567 | ||
| 996 | ‡2 LC|n 2009050821 | ||
| 996 | ‡2 SUDOC|122762126 | ||
| 996 | ‡2 BNF|12379958 | ||
| 996 | ‡2 BNCHL|10000000000000000841404 | ||
| 996 | ‡2 BNC|981058513735606706 | ||
| 996 | ‡2 DNB|1158233442 | ||
| 996 | ‡2 BNCHL|10000000000000000044034 | ||
| 996 | ‡2 LC|no2009120837 | ||
| 996 | ‡2 NTA|330625233 | ||
| 996 | ‡2 ISNI|0000000116109877 | ||
| 996 | ‡2 NII|DA0975752X | ||
| 996 | ‡2 SUDOC|280364326 | ||
| 996 | ‡2 LC|n 95066606 | ||
| 996 | ‡2 SUDOC|257093982 | ||
| 996 | ‡2 BIBSYS|1678650009559 | ||
| 996 | ‡2 BIBSYS|1006498 | ||
| 996 | ‡2 RERO|A008680531 | ||
| 996 | ‡2 BNE|XX1015316 | ||
| 996 | ‡2 NTA|41822904X | ||
| 996 | ‡2 ICCU|CUBV115806 | ||
| 996 | ‡2 DNB|134387686 | ||
| 996 | ‡2 LC|ns2016001172 | ||
| 996 | ‡2 DNB|133346781 | ||
| 996 | ‡2 LC|ns2014002382 | ||
| 996 | ‡2 NKC|xx0321082 | ||
| 996 | ‡2 ISNI|0000000076901594 | ||
| 996 | ‡2 BNC|981058517633206706 | ||
| 996 | ‡2 LC|n 85261059 | ||
| 996 | ‡2 ISNI|0000000084037644 | ||
| 996 | ‡2 LC|n 2006007001 | ||
| 996 | ‡2 BNCHL|10000000000000000052373 | ||
| 996 | ‡2 BNE|XX914721 | ||
| 996 | ‡2 BNE|XX1201694 | ||
| 996 | ‡2 BNE|XX5086285 | ||
| 996 | ‡2 BNC|981058518135706706 | ||
| 996 | ‡2 ISNI|0000000059825868 | ||
| 996 | ‡2 BNC|981058509209006706 | ||
| 996 | ‡2 BNE|XX948755 | ||
| 996 | ‡2 SZ|188419969 | ||
| 996 | ‡2 BNC|981060556074806706 | ||
| 996 | ‡2 DNB|139980156 | ||
| 996 | ‡2 DNB|1206255315 | ||
| 996 | ‡2 ISNI|0000000114945994 | ||
| 996 | ‡2 BNE|XX1095320 | ||
| 996 | ‡2 PTBNP|818753 | ||
| 996 | ‡2 NTA|152336214 | ||
| 996 | ‡2 LC|no2001019747 | ||
| 996 | ‡2 DNB|1067157220 | ||
| 996 | ‡2 CAOONL|ncf10207218 | ||
| 996 | ‡2 LC|no 96004936 | ||
| 996 | ‡2 BNE|XX1421136 | ||
| 996 | ‡2 ICCU|UBOV526074 | ||
| 996 | ‡2 LC|no2018131988 | ||
| 996 | ‡2 CAOONL|ncf12139633 | ||
| 996 | ‡2 BNF|12440414 | ||
| 996 | ‡2 LC|n 2004116518 | ||
| 996 | ‡2 LC|nr 94015355 | ||
| 996 | ‡2 BNE|XX1727250 | ||
| 996 | ‡2 BNE|XX1112996 | ||
| 996 | ‡2 BNE|XX1288134 | ||
| 996 | ‡2 NUKAT|n 2005142575 | ||
| 996 | ‡2 BIBSYS|90830901 | ||
| 996 | ‡2 BNE|XX1287027 | ||
| 996 | ‡2 ISNI|0000000059374032 | ||
| 996 | ‡2 LC|no2009036375 | ||
| 996 | ‡2 LC|n 2010055759 | ||
| 996 | ‡2 ISNI|0000000114507070 | ||
| 996 | ‡2 ISNI|0000000027164137 | ||
| 996 | ‡2 BNE|XX5391344 | ||
| 996 | ‡2 LC|ns2015002967 | ||
| 996 | ‡2 PLWABN|9811305234105606 | ||
| 996 | ‡2 BNE|XX1540860 | ||
| 996 | ‡2 LC|n 81146635 | ||
| 996 | ‡2 CAOONL|ncf11069199 | ||
| 996 | ‡2 BNC|981058512117906706 | ||
| 996 | ‡2 SUDOC|083440224 | ||
| 996 | ‡2 LC|ns2019001481 | ||
| 996 | ‡2 BNF|13771950 | ||
| 996 | ‡2 ISNI|0000000043189924 | ||
| 996 | ‡2 LC|no2009072321 | ||
| 996 | ‡2 SUDOC|095116427 | ||
| 996 | ‡2 DNB|115740765X | ||
| 996 | ‡2 BNE|XX4749334 | ||
| 996 | ‡2 LC|no 99069945 | ||
| 996 | ‡2 BNE|XX1125244 | ||
| 996 | ‡2 NSK|000497062 | ||
| 996 | ‡2 BNE|XX5028083 | ||
| 996 | ‡2 BNE|XX1496970 | ||
| 996 | ‡2 DNB|1157338917 | ||
| 996 | ‡2 NTA|323826164 | ||
| 996 | ‡2 ISNI|0000000043435187 | ||
| 996 | ‡2 BNE|XX1286960 | ||
| 996 | ‡2 DNB|131714643 | ||
| 996 | ‡2 SUDOC|111473780 | ||
| 996 | ‡2 LC|no2011018513 | ||
| 996 | ‡2 UIY|000000660 | ||
| 996 | ‡2 ISNI|0000000116384318 | ||
| 996 | ‡2 DNB|171316541 | ||
| 996 | ‡2 BNE|XX853491 | ||
| 996 | ‡2 SUDOC|184293189 | ||
| 996 | ‡2 BNCHL|10000000000000000291736 | ||
| 996 | ‡2 BNE|XX941561 | ||
| 996 | ‡2 ISNI|0000000025555222 | ||
| 996 | ‡2 NSK|000280825 | ||
| 996 | ‡2 SUDOC|098169254 | ||
| 996 | ‡2 J9U|987012329647105171 | ||
| 996 | ‡2 LC|no 00099813 | ||
| 996 | ‡2 SUDOC|182270750 | ||
| 996 | ‡2 DNB|1240508735 | ||
| 996 | ‡2 RERO|A000144319 | ||
| 996 | ‡2 DNB|1057524948 | ||
| 996 | ‡2 LC|no2008121286 | ||
| 996 | ‡2 SUDOC|080788947 | ||
| 996 | ‡2 BIBSYS|6095003 | ||
| 996 | ‡2 BNF|13894594 | ||
| 996 | ‡2 DBC|87097969918077 | ||
| 996 | ‡2 BNF|12120351 | ||
| 996 | ‡2 BNE|XX1286993 | ||
| 996 | ‡2 NUKAT|n 2008076811 | ||
| 996 | ‡2 BLBNB|001593141 | ||
| 996 | ‡2 DNB|188419969 | ||
| 996 | ‡2 BNC|981058610959806706 | ||
| 996 | ‡2 BNE|XX1287201 | ||
| 996 | ‡2 ISNI|0000000382111443 | ||
| 996 | ‡2 BNE|XX1287202 | ||
| 996 | ‡2 RERO|A027336837 | ||
| 996 | ‡2 NTA|374662150 | ||
| 996 | ‡2 RERO|A003336244 | ||
| 996 | ‡2 LC|no2001031408 | ||
| 996 | ‡2 ISNI|0000000060444595 | ||
| 996 | ‡2 ISNI|0000000115185560 | ||
| 996 | ‡2 LC|ns2018001265 | ||
| 996 | ‡2 BNE|XX938827 | ||
| 996 | ‡2 NUKAT|n 2005128511 | ||
| 996 | ‡2 ISNI|0000000095569523 | ||
| 996 | ‡2 SUDOC|193046245 | ||
| 996 | ‡2 NUKAT|n 2019218447 | ||
| 996 | ‡2 LC|no2024035047 | ||
| 996 | ‡2 ISNI|0000000060266207 | ||
| 996 | ‡2 SUDOC|067005632 | ||
| 996 | ‡2 LC|ns2024002366 | ||
| 996 | ‡2 SUDOC|176606157 | ||
| 996 | ‡2 ISNI|0000000036396554 | ||
| 996 | ‡2 BNCHL|10000000000000000071688 | ||
| 996 | ‡2 LC|no2007135323 | ||
| 996 | ‡2 BNE|XX848020 | ||
| 996 | ‡2 RERO|A009957879 | ||
| 996 | ‡2 BNE|XX1257485 | ||
| 996 | ‡2 LC|nr 99011601 | ||
| 996 | ‡2 DNB|1234024225 | ||
| 996 | ‡2 LC|n 81115150 | ||
| 996 | ‡2 DNB|1056316454 | ||
| 996 | ‡2 NTA|204245346 | ||
| 996 | ‡2 BNE|XX951679 | ||
| 996 | ‡2 BNE|XX883183 | ||
| 997 | ‡a 0 0 lived 0 0 ‡9 1 |
